rEVO Biologics Company Profile

00:22 EDT 5th August 2015 | BioPortfolio

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its proprietary rPRO Technology platform -- a scalable, transgenic, and cost-effective method of protein production-- rEVO Biologics is bringing safe and reliable therapeutic proteins to address critical medical needs. The company’s lead product, ATryn® Antithrombin (Recombinant), is the first and only plasma-free antithrombin concentrate. ATryn received FDA approval in 2009. The company has a number of products in its pipeline and in clinical trials in the areas of hematology, oncology, genetic disorders and autoimmune disease, and is actively seeking additional indications for its lead product.


News Articles [379 Associated News Articles listed on BioPortfolio]

Revo Partners With Bono to Fight Vision Impairment and Unnecessary Blindness

"Buy Vision, Give Sight" Campaign Will Help More than 5 Million People by 2020 ...

Biologics World Korea: Counting On A Paradigm Shift In Biologics Market

Biopharmaceutical experts from around the world gathered in Seoul at the recent Biologics World Korea 2015, at which a group of panelists discussed the strategic direction of the biologics industry in...

WuXi Biologics to build world's largest biologics facility

Biospectrum Upon completion the new facility will further expand WuXi's already extensive biologics manufacturing capab...

CMC Biologics schließt kommerziellen Liefervertrag mit Emergent BioSolutions für das von der FDA zugelassene IXINITY® ab

- Das Produkt wird im Werk von CMC Biologics in Seattle, Washington, hergestellt - Seattle (ots/PRNewswire) - CMC Biologics, Inc. [http://www.cmcbiologics.com/], ein weltweiter Vertragshersteller (...

Qu Biologics to work with University of Rochester

Vancouver, BC – Qu Biologics Inc. reports it has initiated a research collaboration with the laboratory of Dr. Michael R. Elliott of the University of Rochester School of Medicine and Dentistry....

Biologics Are Revolutionizing Care for Some Diseases, But They Are Very Costly

(Washington Post) – Biologics are different from chemically derived drugs such as antibiotics: They are made from living organisms and require special handling in a controlled temperature while ...

New anorexia treatment in the works? Cambridge startup gets $28.3M to develop biologics that restore homeostasis

Biologics are typically used as therapeutics, but a Cambridge startup is using precise protein chemistry to move the field a little closer to the nutraceutical space. Pronutria‘s biologics are ...

Biosimilars: Improving Patient Access To Biologics While Bending The Cost Curve

Zarxio is the first in an expected wave of US biosimilar approvals as blockbuster originator biologics go off patent. Just as market competition for small molecules has proven to be healthy for both g...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [71 Associated PubMed Articles listed on BioPortfolio]

The Cost-Effectiveness of Biologics for the Treatment of Rheumatoid Arthritis: A Systematic Review.

Economic evaluations provide information to aid the optimal utilization of limited healthcare resources. Costs of biologics for Rheumatoid arthritis (RA) are remarkably high, which makes these agents ...

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States.

Aaron Kesselheim and colleagues examine potential strategies to promote greater prescribing of generic drugs and follow-on biologics.

Progress and Hurdles for Follow-on Biologics.

In March 2015, the Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio), Sandoz's version of the leukocyte growth factor Neupogen, an Amgen drug indicated for conditions including neut...

Biologics in Spine Arthrodesis.

Cervical and lumbar spine arthrodesis is performed in the treatment of spine trauma, tumors, and degenerative disorders with an estimated 200,000 fusion procedures performed in the United States annua...

Biologics in dermatology: adverse effects.

Biologics are a group of drugs that precisely affect certain specific steps in the immune response and are an extremely useful group when used in an appropriate setting. However, their use can often b...

Clinical Trials [33 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) ...

Positron Emission Tomography in Rheumatoid Arthritis With Adalimumab (PETRA)

Biologics are routinely used for the treatment of rheumatoid arthritis (RA). Adalimumab is a human monoclonal antibody that inhibit the Tumor Necrosis Factor alpha (TNF-alpha). Identificat...

Companies [201 Associated Companies listed on BioPortfolio]

rEVO Biologics

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recom...

rEVO Biologics Inc.

rEVO Biologics Inc. (www.revobiologics.com) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address ...

rEVO Biologics, Inc.

rEVO Biologics, Inc. (www.revobiologics.com) is a commercial-stage biopharmaceutical company focused on the development and commercialization of specialty therapeutics to address ...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

Precision Biologics, Inc.

Founded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic ...

More Information about "rEVO Biologics" on BioPortfolio

We have published hundreds of rEVO Biologics news stories on BioPortfolio along with dozens of rEVO Biologics Clinical Trials and PubMed Articles about rEVO Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of rEVO Biologics Companies in our database. You can also find out about relevant rEVO Biologics Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Nutrition
Latest News Clinical Trials Research Drugs Reports Corporate
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Blood
Latest News Clinical Trials Research Drugs Reports Corporate
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record